20 articles
New research reveals intermittent fasting forces immune memory cells from their protective niches, potentially compromising long-term immunity.
New research reveals mortality from this rare immune disorder varies by time, potentially improving treatment strategies.
Researchers develop standardized lung washing procedure that rapidly improves breathing and quality of life in patients with rare disease.
A new review reveals how cellular crosstalk, non-coding RNAs, and lung microbiota drive pulmonary fibrosis โ and where treatments may break through.
RA patients with interstitial lung disease show accelerated cellular aging markers โ shorter telomeres and fewer mitochondrial DNA copies than RA patients without lung involvement.
Scientists identify key mechanism that determines why some immune thrombocytopenia patients maintain remission after stopping treatment.
Researchers uncover how the STING immune pathway triggers mitochondrial fragmentation and DNA release, fueling deadly lung inflammation in sepsis.
Researchers tested whether eosinophil ฮฒ1 integrin activation in blood could track disease activity, potentially sparing patients repeat invasive procedures.
A Phase 4 trial compares two antiretroviral strategies in treatment-naive HIV patients with dangerously low CD4 counts below 100.
Phase 1 trial examines whether vesatolimod can safely stimulate immune response in HIV controllers during treatment interruption.
A pilot study finds one 30-minute PAPIMI electromagnetic field session significantly reduced pain scores and raised parasympathetic HRV markers in chronic musculoskeletal pain patients.
New research shows how targeted interleukin-2 treatment can restore regulatory T cells and reduce muscle inflammation in autoimmune conditions.
Go beyond inflammaging basics to understand how aging reshapes immune cell populations, triggers the SASP, and locks the body into a state of chronic low-grade inflammation at the molecular level.
Pyruvate, a core metabolic molecule, suppresses interferon signaling by directly modifying STAT1 โ linking metabolism to immune control.
Major study shows evolving therapies reduced lung disease progression from 21% to 12% in systemic sclerosis patients over the past decade.
New research identifies Lp-PLA2 enzyme as therapeutic target for deadly lung disease affecting millions of workers worldwide.
Discover how persistent low-grade inflammation drives the aging process and learn strategies to combat this silent threat to longevity.
A phase 1/2 trial finds low-dose oral NMN safely raises platelet counts in steroid-refractory ITP via a novel immunometabolic mechanism.
New research reveals how IL-35 therapy prevents neutrophil trap formation, offering hope for cigarette smoke-worsened asthma.
A mechanistic deep-dive into cutting-edge anti-inflammaging interventions โ from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.
